EDX Medical publishes Annual Report and Notice of AGM

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at Mezzanine Room, 1 Wimpole Street, Westminster, London, W1G 0AE on 30 September 2024 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2024, Notice of AGM and Form of Proxy will be posted today, 4 September 2024, to eligible shareholders.

31Mar24-EDX-Medical-Group-plc-ARA-final Download

Share on:

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group plc

Latest Company News

AIM admission marks new phase for EDX Medical’s diagnostic expansion

June 3, 2026

EDX Medical has joined AIM as it advances the commercial rollout of diagnostic tests targeting cancer and other major diseases, supported by growing clinical screening programmes.

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

May 20, 2026

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests.

EDX Medical begins trading on AIM following move from Aquis

May 13, 2026

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies.